Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population-Reference-Cited by-同舟云学术

Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population

Published:2021-11 Issue:11 Volume:29 Page:1355-1360
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Binmahfouz Lenah S.^ORCID,Bagher Amina M.^ORCID

Funder

Deanship of Scientific Research, King Saud University

King Abdulaziz University

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference28 articles.

1. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients;An;Clin. Exp. Pharmacol. Physiol.,2012

2. Prevalence and Determinants of Over-the-Counter Analgesics Usage among Patients attending Primary Health Care Centers in Jeddah Saudi Arabia;Babakor;J. Young Pharm.,2018

3. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk;Brockmöller;Cancer Res.,1996

4. A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism;Chen;Drug Metab. Rev.,2019

5. Cyp2e1;Gonzalez;Drug Metab. Dispos.,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin;Molecular Biology Reports;2024-07-23

2. Evaluation of Metabolism-Dependent Drug Toxicity;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024